US Patent Issued to Talis Biomedical on April 15 for "Polynucleotides for the amplification and detection of chlamydia trachomatis" (California Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,999, issued on April 15, was assigned to Talis Biomedical Corp. (Chicago).

"Polynucleotides for the amplification and detection of chlamydia trachomatis" was invented by Matthew B. Lee (San Jose, Calif.) and Hedia Maamar (San Jose, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides methods and compositions for the detection of Chlamydia trachomatis in a test sample. Its presence or absence in the sample is determined by nucleic acid based testing methods using primers and/or probes and or molecular beacons that bind to the 16S or 23S ribosomal genes or gene transcripts."

The patent was filed on Nov. 13, 2017, under Applicat...